SEC
SlamSEC
SearchBrowseEarnings

MERRIMACK PHARMACEUTICALS INC

Pharmaceutical Preparations·CAMBRIDGE, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(807 total)

TypeDateAccessionPeriodSize
15-12G
May 20, 2024
0001193125-24-14283715-12G
—
11.6 KB
10-Q
May 15, 2024
0000950170-24-06047810-Q
Mar 31, 2024
3.3 MB
25
May 10, 2024
0001193125-24-136243FORM 25
—
11.8 KB
8-K
May 10, 2024
0001193125-24-136237FORM 8-K
May 10, 2024
185.3 KB
DEFA14A
May 9, 2024
0001193125-24-134775DEFA14A
—
55.6 KB
8-K
May 9, 2024
0001193125-24-134773FORM 8-K
May 8, 2024
193.0 KB
DEFA14A
Apr 30, 2024
0001193125-24-125372DEFA14A
—
57.8 KB
8-K
Apr 30, 2024
0001193125-24-1253678-K
Apr 30, 2024
196.6 KB
DEFR14A
Apr 1, 2024
0001193125-24-083441DEFR14A
—
605.5 KB
DEFA14A
Mar 27, 2024
0001193125-24-078920DEFA14A
—
52.6 KB
8-K
Mar 27, 2024
0001193125-24-0789108-K
Mar 27, 2024
189.5 KB
DEFA14A
Mar 22, 2024
0001193125-24-074722DEFA14A
—
55.6 KB
DEF 14A
Mar 21, 2024
0001193125-24-073941DEF 14A
May 10, 2024
947.9 KB
10-K/A
Mar 21, 2024
0001193125-24-07392910-K/A
Dec 31, 2023
447.6 KB
425
Mar 7, 2024
0001193125-24-062268425
—
48.7 KB
8-K
Mar 7, 2024
0001193125-24-0622608-K
Mar 7, 2024
183.1 KB
10-K
Mar 7, 2024
0000950170-24-02796610-K
Dec 31, 2023
4.9 MB
SC 13G/A
Mar 7, 2024
0001086364-24-007251
—
12.1 KB
PRE 14A
Mar 5, 2024
0001193125-24-059357PRE 14A
Mar 5, 2024
1.1 MB
SCHEDULE 13G
Feb 22, 2024
0001758866-24-000002
—
15.2 KB
SC 13G/A
Feb 14, 2024
0000921895-24-000491AMENDMENT NO. 4 TO THE SCHEDULE 13G
—
150.3 KB
DEFA14A
Feb 13, 2024
0001193125-24-033779DEFA14A
—
58.9 KB
8-K
Feb 13, 2024
0001193125-24-0337618-K
Feb 13, 2024
198.2 KB
SC 13G
Jan 31, 2024
0001086364-24-006061
—
13.0 KB
SC 13D/A
Jan 25, 2024
0001493152-24-003744
—
196.2 KB
25 filings shown

Merrimack Pharmaceuticals, Inc. is a pharmaceutical company based in Cambridge, Massachusetts, United States.